Lactaid Tab 3300unit 3300 Unit Tablet is a Health Canada–registered human drug (DIN 01936859) held by Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc, containing Lactase. Health Canada lists its status as Cancelled Post Market (status date 10 Aug 1998). Nexara Health has matched 5 registrations of Lactase across 3 other regulated markets.
Health Canada registration
| DIN | 01936859 |
|---|---|
| Brand name | Lactaid Tab 3300unit |
| Active ingredient | Lactase |
| Strength | 3300 Unit |
| Dosage form | Tablet |
| Route | Oral |
| Company | Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc |
| Status | Cancelled Post Market — 10 Aug 1998 |
| Class | Human |
| ATC | |
| AHFS | 12:12.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Lactase registered in other markets
5 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Jordan | Advancis® Colibaby. | Labialfarma – Laborat?rio de Produtos Farmacêutidos e Nutracêuticos S.A. | 25 ML/50 ML | Oral solution | NEW APPLICATION | JFDA drug registrations |
| Malaysia | Lactzym Lactase 45mg tablets | Quanstar Biotech Sdn Bhd | Health Supplement | PRODUCT APPROVED | NPRA | |
| United Arab Emirates | Delictase | LECIFARMA-ESPECIALIDADES FARMACEUTICAS E PRODUTOS GALENICOS, LDA., Portugal, Loures | 30 mg | Capsule | Active | EDE |
| United Arab Emirates | Delictase Oral Drops | LECIFARMA-ESPECIALIDADES FARMACEUTICAS E PRODUTOS GALENICOS, LDA., Portugal, Loures | 9.75 ml/15ml | Drops | Active | EDE |
| United Arab Emirates | Lactacol® Capsules | salix srl, Italy, Monte di malo | 30mg/Capsule | Capsule | Active | EDE |
See every manufacturer of Lactase worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Lactaid Tab 3300unit (DIN 01936859) marketed in Canada?
No. Health Canada lists DIN 01936859 as Cancelled Post Market as of 10 Aug 1998.
Who holds the Canadian licence for this product?
Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc is the company of record in the Health Canada Drug Product Database.
Is Lactase registered outside Canada?
Yes — Nexara Health has matched 5 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01936859, status date 1998-08-10; national medicine registries: EDE, JFDA drug registrations, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01936859, status date 1998-08-10; national medicine registries: EDE, JFDA drug registrations, NPRA.
Health Canada Drug Product Database (DPD), DIN 01936859, status date 1998-08-10; national medicine registries: EDE, JFDA drug registrations, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.